MedTrace Logo

Efficacy Study of a Cosmetic Lotion in the Treatment of Androgenetic Alopecia in Males and Females

NCT01701271 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2016-02-17

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to determine whether the Hair Loss Prevention Lotion named MEXIS, M.P.A.F., M6S PATENT is effective in the treatment of Androgenetic Alopecia.

Conditions

Interventions

OTHER

Hair loss prevention lotion

For greatest problems 20 drops on the scalp per day for 3 months. For minor problems 10 drops on the scalp three times per week for 3 months.

Sponsors & Collaborators

  • Mexis George

    lead OTHER

Principal Investigators

  • Fulvio Marzatico, Monitor · Bio Basic EuropeResearch, Development and Dermo-Cosmetoligical Documentation

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2001-02-28
Primary Completion
2001-06-30
Completion
2001-06-30

Countries

  • Greece

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01701271 on ClinicalTrials.gov